COST-EFFECTIVE EVALUATION OF INDETERMINATE URINARY CYTOLOGY
- 1 September 1998
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 160 (3 Part 1) , 734-736
- https://doi.org/10.1016/s0022-5347(01)62771-x
Abstract
Conclusions Patients with indeterminate urinary cytology who are nonsmokers and have neither hematuria nor a history of urothelial cancer are at low risk for malignancy and do not warrant complete evaluation.Keywords
This publication has 8 references indexed in Scilit:
- Initial Evaluation of the Bladder Tumor Antigen Test in Superficial Bladder CancerJournal of Urology, 1996
- Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder CancerJournal of Urology, 1995
- Papillary transitional‐cell carcinoma of the upper urinary tract: A cytological reviewDiagnostic Cytopathology, 1990
- Bladder cancer risk and pipes, cigars, and smokeless tobaccoCancer, 1985
- An International Study of Smoking and Bladder CancerJournal of Urology, 1984
- Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasmsCancer, 1984
- Pathological Changes Associated With Topical Chemotherapy for Superficial Bladder CancerJournal of Urology, 1981
- Urine Sediment Smears as a Diagnostic Procedure in Cancers of the Urinary TractScience, 1945